In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

GSK, AZ, Univ. of Manchester invest in translational inflammation research

Executive Summary

GlaxoSmithKline PLC, AstraZeneca PLC, and the University of Manchester have agreed to form the Manchester Collaborative Centre for Inflammation Research (MCCIR), which will focus on rapidly translating basic research into medicines for chronic inflammatory diseases, including asthma, COPD, rheumatoid arthritis, and IBD.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • R&D and Marketing (Licensing)

Related Companies